About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 452 record(s)
Req # A-2022-872
All records containing the words "Enterprise Canada" and/or "Brian Fox." Limit to records held by CSIS director, executive director of ITAC, and deputy director operations from 2021 12 01 to present.Organization: Canadian Security Intelligence Service
December 2022
Req # A-2022-887
All communications that the CSIS director, David Vigneault, had with Chrystia Freeland between 2022 01 23, and 2022 02 14 including all notes taken during meetings or phone calls (conference calls), schedules, briefing notes, text messages, emails, call logs and recordings.Organization: Canadian Security Intelligence Service
December 2022
Req # A-2022-930
The inventory of all dangers that are identified as "normal condition of employment" at CSIS and inline with Canada Labor Code Part II requirements for the period of 2000 01 to 2022 12.Organization: Canadian Security Intelligence Service
December 2022
Req # A-2018-001621
Adverse Drug Reactions (ADRs). Report numbers: E2B_01876090, E2B_01338065, E2B_02190267, E2B_01942726, E2B_01475225, E2B_01776362, E2B_01955738, E2B_01940173Organization: Health Canada
December 2022
Req # A-2019-001654
Adverse Drug Reactions (ADRs) for PREDNISOLONE. Report numbers: 000719680, E2B_02529865, E2B_02030519, E2B_02515291, E2B_02050563, E2B_02484589, E2B_02564514, E2B_02644290, E2B_02409379, E2B_02405284, E2B_02564514, E2B_02283612, E2B_02288634, E2B_02340759, E2B_02343409, E2B_02110537, E2B_02197044, E2B_02231445, E2B_02094176, E2B_02251355.Organization: Health Canada
December 2022
Req # A-2020-000123
Adverse Drug Reaction (ADR). Report number: 000731022.Organization: Health Canada
December 2022
Req # A-2020-001368
Adverse Drug Reactions (ADRs) for ENOXAPARIN SODIUM. Report numbers: 000908390, 000912874.Organization: Health Canada
December 2022
Req # A-2020-001861
Adverse Drug Reactions (ADRs) for Janumet. Report numbers: E2B_01294965, E2B_01319676, E2B_01387851, E2B_01648958, E2B_00412992, E2B_01322417, E2B_01653190, E2B_00280827.Organization: Health Canada
December 2022
Req # A-2021-001526
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03523213, 953443, E2B_03577001, E2B_03733340, E2B_03526016, E2B_03525423, E2B_03693115, E2B_03698695, E2B_03753478, E2B_03726769, E2B_03578415, E2B_03753511, E2B_03767290, E2B_03736254, E2B_02529659, E2B_03705225, E2B_03791084, E2B_03774153, E2B_03753476.Organization: Health Canada
December 2022
Req # A-2021-001643
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 000960133, 000958602, 000960030, 000958306, E2B_04307622, 000963494, 000961224, E2B_04231900, 000962867, 000960982, E2B_04241704, 000966094, E2B_04465758, E2B_04459597, E2B_04446085, 000963841, 000961474.Organization: Health Canada
December 2022